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Objectives. We evaluated the sensitivity and specificity of 
exercise-induced ST segment elevation for the detection of resid- 
ual myocardial viability. 
Background. Assessment of residual viability after myocardial 
infarction is relevant for establishing indication for revascular- 
ization. We have previously shown that exercise.induced ST 
segment elevation is a marker of residual viability. 
Methods. We studied 34 patients with a previous Q wave 
myocardial infarction (anterior in 21, inferior in 13) of whom 18 
(group A) had exercise-induced ST segment elevation in more 
than one lead (mean [-+SD] 1.8 _+ 0.9 mm, range 1 to 4) and 16 
(group B) did not. All patients underwent rest technetium-99m 
methoxyisobutyl isonitrile single-photon emission computed to- 
mography (SPECT), fluorine-18 (F-18) fluorodeoxyglucose 
positron emission tomography and coronary angiography. The 
time elapsed between the infarction and the viability study was 
72 -+ 108 days (range 15 to 400) in group A and 516 -+ 545 days 
(range 14 to 1,800) in group B. 
Results. The presence and site of previous infarction were 
confirmed by SPECT studies in all 34 patients. Uptake of F-18 
fluorodeoxyglucose within the infarcted area was present in 18 of 
18 patients in group A but in only 9 (56%) of 16 in group B (p < 
0.01). In patients with an anterior infarction, the sensitivity, 
specificity and predictive accuracy of exercise-induced ST segment 
elevation for detection of residual viability were 82%, 100% and 
86%, respectively (95% confidence intervals 46% to 83.5%, 59% to 
100% and 55.6% to 87.1%, respectively). 
Conclusions. Exercise-induced ST segment elevation in infarct- 
related leads has a high specificity and acceptable sensitivity for 
detection of residual viability within the infarcted area. 
(J Am CoU Cardiol 1995;25:1032-8) 
The differentiation f myocardial regions with complete infarc- 
tion from those containing viable, potentially salvageable isch- 
emic tissue is of paramount importance for deciding whether 
revascularization may be indicated. Improved contraction of 
dysfunctional myocardium after nitroglycerin administration 
(1), ventricular ectopic beats (2), exercise (3) or inotropic 
agents (4) has been used to assess residual viability. Thallium- 
201 stress-redistribution (5) and reinjection (6) scintigraphy, 
as well as dipyridamole stress echocardiography (4),have also 
been used to differentiate r versible and irreversible damage. 
More recently, myocardial glucose metabolic imaging by 
positron emission tomography has been proposed as the 
reference standard technique for identification of severely 
ischemic yet metabolically active myocardium (7). 
We previously showed (8) that exercise-induced ST seg- 
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ment elevation on infarct-related lectrocardiographic (ECG) 
leads is almost invariably associated with a reversible perfusion 
defect on thallium-201 myocardial perfusion scintigraphy. On 
the basis of this observation we suggested that, at least in 
patients with recent myocardial infarction, transient ST seg- 
ment elevation may indicate residual viability because the 
occurrence of reversible ischemia within the infarct zone 
implies, by definition, persistence ofviable, potentially salvage- 
able myocardium. 
However, in the context of perinecrotic ischemia, the 
significance of postexercise thallium-201 redistribution is not 
fully understood (9). Furthermore, when compared with met- 
abolic imaging with fluorine-18 (F-18) fluorodeoxyglucose 
positron emission tomographic conventional thallium-201 re- 
distribution scintigraphy has a considerably ower sensitivity 
for detecting residual viability (10). 
Therefore, to gain further insight into the significance of 
exercise-induced ST segment elevation, we undertook the 
present study aimed at correlating the occurrence of exercise- 
induced ST segment elevation with the presence of metaboli- 
cally active tissue. To this end, we used F-18 fluorodeoxyglu- 
cose positron emission tomographic maging, the reference 
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standard investigation technique for detection of myocardial 
viability. 
Methods  
Patients. We prospectively studied 34 consecutive patients 
(28 men, 6 women; mean [_+SD] age 55 _+ 9 years, range 33 to 
75) with a Q wave myocardial infarction. The diagnosis was 
based on a history of typical and prolonged chest pain, serial 
ECG recordings and serum enzyme determinations. Diagnosis 
was confirmed by the echocardiographic demonstration of
regional wall motion abnormalities in the region explored by 
the ECG leads with abnormal Q waves. Fourteen patients were 
studied uring the hospital period after the acute infarction, 
and the remaining 20 were enrolled from our outpatient clinic 
to which they had been sent for prognostic stratification. All 
were in New York Heart Association functional class I or II. 
Patients with left ventricular hypertrophy, valvular heart 
disease or left or right bundle branch block or taking drugs 
known to affect the ST segment were excluded. Those with 
overt diabetes or impaired glucose tolerance were also ex- 
cluded. 
The protocol was approved by the ethics committee ofour 
institution, and each patient gave written informed consent to 
participate in the study. 
Exercise testing. All patients underwent maximal exercise 
testing on a treadmill using a computer-assisted xercise 
system (Case 12 Marquette Electronics Inc.,) according to the 
modified Bruce protocol. Exercise was performed on the 
morning after an overnight fast. Antianginal medications were 
stopped at least 72 h before the test, and only sublingual 
nitrates were allowed for up to 6 h before the test to relieve 
chest pain. A 12-lead ECG and systolic and diastolic blood 
pressure (cuff sphygmomanometer) were recorded at rest, 
during the third minute of each exercise stage, at peak exercise, 
1 rain after exercise and every 2 min into recovery. Leads II, V 1 
and V 5 were continuously monitored. The test was terminated 
when the target heart rate was achieved; when severe chest 
pain, dyspnea, fatigue, complex ventricular arrhythmias or 
hypotension ccurred; or when ST segment depression > 1 mm 
developed. ST segment elevation in infarct-related leads was 
not in itself considered a reason for exercise termination. 
Maximal predicted heart rate was calculated 220 minus age. 
Interpretation of ST segment deviation was performed in 
blinded manner by two independent observers. Disagreement 
was resolved by consensus. Exercise-induced ST segment ele- 
vation >1 mm above the baseline ST segment level (80 ms 
after the J point) in more than one ECG lead with abnormal 
Q waves was considered significant. When present, diagnostic 
ST segment depression on noninfarct-related l ads was also 
noted. 
Positron emission tomographic studies of myocardial glu- 
cose metabolism. Regional myocardial glucose metabolism 
was assessed by positron emission tomography, and F-18 
fluorodeoxyglucose was synthesized according to the method 
described by Hamacher et al. (11) with a compact automated 
module connected to the cyclotron (CTI/Siemens RDS 112 
cyclotron, Siemens/CPS). The labeled glucose analogue was 
used within 1 h of its preparation. Positron emission tomo- 
graphic studies were carried out with an ECAT 931/04-12 
tomograph (Siemens/CPS) equipped with germanium-68 re- 
tractable ring sources for transmission scans; transaxial and 
axial field of views were, respectively, 55.5 and 5.4 cm. Blood 
glucose and insulin levels were measured at the time of F-18 
fluorodeoxyglucose injection. To enhance detection of isch- 
emic and yet viable tissue, patients fasted overnight (15 h). 
This method has been shown to be very sensitive for detecting 
areas of viable myocardium (12,13). To correct for photon 
attenuation, two transmission scans were performed in the 
region encompassing the heart, previously identified on a 
rectilinear scan; indelible ink lines that defined the upper limit 
of the positron emission tomographic field of view were drawn 
on the torso. Two consecutive mission scans, each lasting 
10 rain, were carried out between 40 and 60 min after the 
intravenous administration f -250 MBq of F-18 fluorodeoxy- 
glucose. The two emission scans were performed by sliding the 
bed axially to acquire two sets of seven tomographic images of 
radioactivity distribution. Fourteen contiguous slices, 6.75 mm 
thick, were reconstructed in the transaxial plane using the 
Hann filter (cutoff frequency 0.5 cycles/pixel) on a 64 x 64 
matrix. Under these conditions the spatial resolution in the 
transaxial plane was 0.8 cm full-width at half-maximum. 
Single-photon emission computed tomographic studies of 
myocardial perfusion. Because the regional myocardial per- 
fusion study was only meant to identify the infarct area 
potentially containing residual viable tissue, no attempt was 
made to quantify perfusion, which was assessed by single- 
photon emission computed tomography (SPECT) on the day 
after the positron emission tomographic metabolic study. 
Seven hundred forty megabecquerels of technetium-99m (Tc- 
99m) methoxyisobutyl isonitrile (MIBI) was injected intrave- 
nously. A standard cholecystokinetic fatty meal was provided 
30 rain after injection, and tomographic imaging was started 
within 90 min of tracer injection, using a large field of view, 
single-head rotating amma camera (either a STARCAM 400 
AC, General Electric or a 7500 Orbiter, Siemens, Erlangen, 
Germany) equipped with a high resolution, low energy paral- 
lel-hole collimator and interfaced with a dedicated computer. 
Just before the SPECT studies, radioactive xternal markers 
were placed on the torso at the level of the indelible ink lines 
that defined the upper limit of the positron emission tomo- 
graphic field of view. Sixty-four angular projections (64 × 64 
matrix) were obtained in -40 rain over 360 °. Transaxial slices, 
6.2 cm thick, were reconstructed using a filtered back- 
projection algorithm with a Butterworth filter (cutoff requency 
0.4 cycles/pixel). No attenuation correction was performed. 
Spatial resolution i  the transaxial plane was 1.8-cm full-width 
at half-maximum. 
Combined positron emission tomographic and SPECT 
assessment. A semiquantitative analysis was carried out on 
tomographie images of perfusion and metabolism by dividing 
the left ventricle into six segments: anterior, apical, inferior, 
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Figure 1. Subdivision of the left ventricle into six segments on 
tomographic images. 
lateral, posterior and septal (Fig. 1). The positron emission 
tomographic and SPECT data were transferred to a SUN 
workstation (SUN 4/330, SUN Microsystem) for image pro- 
cessing and integration through an Ethernet network connec- 
tion. The reconstruction f the SPECT transaxial slices was 
started from the level defined by the radioactive markers, 
consistent with the upper limit of the positron emission 
tomographic field of view, to match corresponding transaxial 
slices in the SPECT and positron emission tomographic stud- 
ies. Images were decoded and converted to a standard file 
format. The SPECT and positron emission tomographic 
transaxial slices were realigned along the horizontal and ver- 
tical long and short axis with a commercially available software 
(Image tool, Siemens, Erlangen, Germany). 
Corresponding positron emission tomographic and SPECT 
images were displayed on a color TV screen in random order 
and analyzed in blinded manner by two experienced observers 
for the presence of F-18 fluorodeoxyglucose uptake within 
underperfused areas. 
Each F-18 fluorodeoxyglucose positron emission tomo- 
graphic image was displayed together with the matching per- 
fusion slice, and circular egions of interest, 1 cm in diameter, 
were drawn in the areas of the left ventricular wall correspond- 
ing to the underperfused region (Fig. 3). Counts/pixel were 
measured in each region of interest, and values from two to 
five discrete regions of interest from each segment were 
averaged to obtain a mean segmental value. A segmental index 
of F-18 fluorodeoxyglucose uptake was calculated by dividing 
the mean value of counts/pixel in each segment by the mean 
value of counts/pixel in the ventricular cavity. Underperfused 
tissue was defined viable when the F-18 fluorodeoxyglucose 
index was above the 95% confidence interval defined in six 
segments from five normal subjects tudied in the fasting state. 
Left ventriculography and coronary angiography. Selec- 
tive coronary angiography and left ventriculography were 
performed by the Judkins technique. Biplane left ventriculog- 
raphy was performed in the 30 ° right anterior and 60 ° left 
anterior oblique projections. The left ventricular silhouette 
was divided into seven segments whose regional wall motion 
was scored according to the recommendations f the American 
Heart Association (14) using the following scale: grade 0 = 
normal; grade I = hypokinesia (reduced systolic wall motion); 
grade 2 = akinesia (no systolic wall motion); and grade 3 = 
dyskinesia (paradoxic systolic expansion). A global eft ventric- 
ular dysfunction score was then obtained by adding the scores 
of single segments. The left and right coronary arteries were 
imagined in multiple views, including craniocaudal projections. 
Coronary artery stenosis was considered significant if the 
lumen diameter was narrowed by ---50%. The extent of retro- 
grade collateral opacification of occluded vessels was also 
assessed and graded according to the classification of Cohen 
and Rentrop (15). The studies were evaluated by two observers 
in blinded manner. 
Correlations between ST segment changes and positron 
emission tomographic imaging. Using F-18 fluorodeoxyglu- 
cose positron emission tomography asthe reference standard 
for determining the presence of tissue viability, the occurrence 
of ST segment elevation on the exercise ECG was considered 
a true positive result when the change involved leads with 
abnormal Q waves corresponding to an area with increased 
F-18 fluorodeoxyglucose uptake; a false positive when the ST 
segment elevation did not correspond to an area with in- 
creased F-18 fluorodeoxyglucose uptake; atrue negative when 
no ST segment elevation and no F-18 fluorodeoxyglucose 
uptake in the corresponding area were observed; a false 
negative when no ST segment elevation was seen in the 
presence of increased F-18 fluorodeoxyglucose uptake in the 
infarct area. The sensitivity, specificity and predictive accuracy 
of exercise-induced ST segment elevation in detecting the 
presence of residual tissue viability within an area of Q wave 
myocardial infarction were determined using the following: 
Sensitivity = True positive/(True positive + False negative); 
Specificity = True negative/(True n gative + False positive); 
and Predictive accuracy = (True positive + True negative)/ 
(True Positive + True Negative + False positive + False 
negative). 
Statistics. Data are presented as mean value -- SD. Statis- 
tical significance of continuous variables was determined with 
a two-tailed Student test. Parametric variables were com- 
pared by the chi-square test. Regional myocardial wall motion, 
perfusion and metabolism were compared using two-way anal- 
ysis of variance. Comparisons between subgroups concerning 
the time from infarction and patency of the infarct-related 
vessel were performed using Bonferroni probability proce- 
dures. Statistical significance was assumed when the null 
hypothesis could be rejected at p = 0.05. 
Resul ts  
Clinical and ECG data. Eighteen patients (15 men, 3 
women; mean [_+SD] age 57 -+ 8 years, range 42 to 75) had 
exercise-induced ST segment elevation (mean 1.8 _+ 0.9 ram, 
range 1 to 4) in more than one infarct-related lead and 
constituted group A (Table 1). Of these, 14 patients (78%) had 
an anterior and 4 (22%) an inferior myocardial infarction. 
Sixteen patients (13 men, 3 women; mean age 54 _+ 9 years, 
range 33 to 72), also with Q wave myocardial infarction 
(anterior in 7 [44%], inferior in 9 [56%]) but with no ST 
segment elevation in the infarct-related leads during exercise 
testing, constituted group B (Table 2). In both groups, the ST 
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Table 1. Clinical, Electrocardiographic, S intigraphic and Angiographic Data for 18 Group A Patients With ST Segment Elevation 
Exercise Stress Test 
Tc-99m PET F- 18 
Pt Age (yr)/ Rest ECG Chest MIBI FDG Coronary Angiogram 
No. Gender Q Wave ST Elev ST Dep Pain SPECT Uptake (% stenosis) LVWMA 
1 53/M I, aVL, V~-V 5 I, aVL, V 3 V~, - - A, L, S - 
2 62/M 11, llI, aVF, V,, Ill, aVF, V, - I, P + 
3 58/M V2-V 5 aVL, V~-V s III, aVF A, S + 
4 44/M V~-V 5 V3-V 5 A, S + 
5 55/M II, Ill, aVF, II, lII, aVF, V 5, V 6 * l, P + 
Vs, V~ 
6 50/M V~-V~, V 2 V~, + A, Ap, S + 
7 67/M II, llI, aVF III, aVF 1, aVL, V2, + P, L, I 
V3 
8 53/M lI, III, aVF, II, III, aVF V~-V,, I, P + 
Vs, V~, 
9 42/M V IV  3 Vz-V s II, III, aVF A, Ap + 
l0 55/F aVL, VrV  3 VI-V 4 - S, A + 
1 [ 60/M V2-V 6 V:~, V 4 + A + 
12 60/M aVL, VI-V 3 aVL, Vz-V 4 II, Ill, aVF, S, A + 
V, 
13 65/M aVL, V~, V 2 V~, V~ II, III, aVF, + A, Ap, S + 
V s, V{, 
14 65/F VI-V 2 V 2, V:~ - A, Ap, S + 
15 59/M V2-V¢, aVL, V2-V 5 - + A, I, P, P1, S + 
16 75/M V2-V ~ V3, V a - 1, S, A + 
17 51/M V3-V ~ V2-V. s - A, Ap, S + 
18 50/F Vj V 5 V2-V ~ A, L + 
LAD 100%, RC 40%, Coil (Ak)Ab, A1, Ap, S 
to LAD 
LAD 40%, RC 100%, Coll (Ak)l, Pb, (Hyp)Ap, S 
to RC 
LAD 60%, LCx 60% (Ak)AI, Ap, S, (Hyp) 
LAD 100%, LCx 40%, (Ak)AI, S, (Dysk)Ap, 
Coll to LAD (Hyp)I 
LAD 60%, LCx 100%, RC (Ak), Pb, (Dysk)Ap, 
100%, Coll to RC (Hyp)P1 
LAD 100%, Coil to LAD (Ak)Ap, I, S, (Dysk)A1 
RC 100%, Coil to RC (Ak)Ap, Pb, (Hyp)I, PI 
LCx 40%, RC 10(1%, Coll (Ak)Pb, PI, (Hyp)Al, Ap, I 
to RC 
LAD 100%, Coll to LAD (Ak)Ap, (Hyp)S 
LAD 75% (Ak)Ab, Al, Ap 
LAD 100%, LCx 100%, (Ak)AI, Ap, S 
Coil to LAD 
LAD 90% (Ak)AI, S, (Dysk)Ap 
LAD 100%, LCx 50%, 
Coil to LAD 
LAD 100%, LCx 40% 
LAD 60%, RC 60% 
LAD 100%, Coll to LAD 
LAD 100%, Coll to LAD 
LAD 100%, Coil to LAD 
(Hyp)Al, Ap, S 
(Ak)al, Ap, S 
(Ak)A1, Ap, (Hyp)Ab, I 
(Ak)AI, Ap, S, (Hyp)I 
(Ak)A1, Ap, S 
(Ak)AI, Ap, S 
A = anterior; Ab = anterobasal; (Ak) - akinesia; AI - anterolateral; Ap - apex; Coll collateral vessels; (Dysk) dyskinesia; ECG electrocardiographic; 
F = female; F-18 FDG fluorine-t8 fluorodeoxyglucose; (Hyp) = hypokinesia; I inferior; L = lateral; LAD left anterior descending coronary artery; LCx - left 
circumflex coronary artery; LVWMA - left ventricular wall motion abnormality; M = male; MIBI = methoxyisobutyl isonitrile; P posterior; Pb = posterobasal; 
PET = positron emission tomographic; PI = posterolateral; Pt = patient; RC = right coronary artery; S = septal; ST Elev - ST segment elevation; ST Dep - ST 
segment depression; Tc-99m MIBI SPECT - technetium-99m MIBI single-photon emission computed tomography; - abscnt; + - present. 
segment on the infarct-related leads was isoelectric or only 
slightly (<1.0 mm) elevated at rest. 
The time interval from infarction to enrollment was 72 + 108 
days (range 15 to 400) in group A and 516 _+ 545 days (range 14 
to 1,800) in group B (p < 0.01). Eight patients in group A (seven 
with an anterior, one with an inferior myocardial infarction) and 
seven in group B (four with an anterior, three with an inferior 
myocardial infarction) had received intravenous thrombolytic 
therapy within 4 h from the onset of chest pain. 
Six patients (33%) in group A and six (38%) in group B had 
ST segment depression that involved noninfarct-related leads 
(p = NS). Six patients (33%) in group A and one (6%) in 
group B had angina during the test (p = 0.05). Total exercise 
time was 686 _+ 252 s in group A and 844 _+ 509 s in group B 
(p = NS). Rate-pressure product at peak exercise was 
21,311 _+ 4,789 beats mm Hg/min in group A and 23,560 _ 
6,193 beats mm Hg/min in group B (p = NS). 
Myocardial perfusion and glucose metabolism. All 34 pa- 
tients in both groups had a perfusion defect consistent with the 
site of previous infarction. There was complete agreement 
between the two observers in all cases. 
All 18 patients in group A had increased F-18 fluorodeoxy- 
glucose uptake in the infarct area. Conversely, only 9 (56%) of 
the 16 patients in group B had evidence of within-infarct 
myocardial viability on the positron emission tomographic 
study (p < 0.01). When only anterior infarctions were analyzed 
in the two groups, all 14 patients in group A had F-18 
fluorodeoxyglucose uptake, whereas only 3 of the 7 patients 
with an anterior infarction in group B had residual metabolic 
activity within the infarct area. A representative xample of 
exercise ECG, SPECT and position emission tomographic data 
obtained in a group A patient is shown in Figures 2 and 3. 
Using F-18 fluorodeoxyglucose positron emission tomog- 
raphy as the reference standard for determining the pres- 
ence of tissue viability, the sensitivity, specificity and pre- 
dictive accuracy of exercise-induced ST segment elevation 
for detecting the presence of residual tissue viability were 
67%, 100% and 74% (95% confidence interval [CI] 46% to 
83.5%, 59% to 100% and 55.6% to 87.1%, respectively) and 
for anterior infarctions, respectively, 82%, 100% and 86% 
(95% CI 56.6% to 96.2%, 39.8% to 100% and 63.7% to 97%, 
respectively). 
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Table 2. Clinical, Electrocardiographic, Scintigraphic and Angiographic Data for 16 Group B Patients Without ST Segment Elevation 
Exercise Stress Test 
Te-99m PET F-18 
Pt Age (yr)/ ST Chest MIBI FDG Coronary Angiogram 
No. Gender Rest ECG Q Wave Elev ST Dep Pain SPECT Uptake (% stenosis) LVWMA 
1 51/M II, II1, aVF - - + I. L 
2 54/M aVL, V~-V3 - I[, llI, aVF - A, S 
3 48/M II, lII, aVF - - - I, P 
4 57/M Vl-V~ - V~-V~ - I. S 
5 59/F I, aVL, V]-V 5 - A, S 
6 62/M V]-V 3 - Vs, V6 
7 47/M V~-V 6 - - 
8 72/F II, III, aVF, Ve, V6 - 
9 47/M II, Ill, aVF 
l0 57/M II, III, aVF - Vs, V~ 
11 55/M II, III, aVF - V~-V6 
12 33/M II, Ill, aVF - - 
13 60/F VrV 6 - - 
14 56/M V~-V~ 
15 44/M II, Ill, aVF - - 
16 59/M II, III, aVF - V3, V s 
A, Ap, I, S ~- 
Ap, A 
L, P + 
S,I L.P 
I, L, P + 
l ,P + 
[ + 
A, Ap, S + 
A,S + 
Ap, l, P + 
I, P + 
LCx 100% (Ak)I, P], (Hyp)Al, Ap, S 
LAD 50% (Hyp)Al, Ap, S 
RC 100%, Coil to RC (Hyp)Ap, I, P] 
LAD 75%, LCx 75%, RC (Hyp)Ap, I, S 
75% 
LAD 100%, LCx 50%, RC (Ak)A, Ap 
50%, Coil to LAD 
LAD 75% (Ak)Ap, S, (Hyp)Al, I, Po, PI 
LAD 100%, LCx 100%, Coil (Ak)AI, (Hyp)Ap, S 
to LAD and LCx 
LAD 60%, LCx 75%, Coil to (Ak)Ap, I, Pl, (Hyp)Al, Pb, S 
RC 
LAD 95%, LCx 80%, RC (Ak)I, S, (Hyp)Al, Ph, S 
60% 
LCx 40%, RC 60% (Hyp)Ap, I, Pb, PI 
D1 100%, RC 100%, Coil to (Ak)Pb, (Hyp)I, PI 
RC 
LCx Irreg (Hyp)I 
LAD 100%, RC 50% (Ak)AI, S, (Dysk)Ap 
LAD 100% (Ak)AI, S 
RC 50% (Ak)Pb, el 
LCx 100%, Coil to LCx (Ak)I, Pb, PI 
D1 = first collateral branch; Irreg = irregular; other abbreviations and symbols as in Table 1. 
Coronary  ang iography  and  left vent r i cu lography .  On con- 
trast ventriculography, all 34 patients had abnormal  left ven- 
tricular wall mot ion in the area explored by leads with abnor- 
mal Q waves. Four  patients (22%) in group A and one (6%) in 
group B had dyskinetic segments. On average, global left 
ventricular dysfunction was significantly greater in group A 
than group B (6.5 -+ 1.6, range 3 to 9; 4.9 + 2.1, range 1 to 9, 
respectively, p < 0.02). 
O f  the 18 patients in group A, 1 had three-vessel disease, 4 
had two-vessel disease, and 13 had one-vessel disease. In 14 
(78%) patient, the coronary artery supplying the infarcted 
territory was occluded. Retrograde filling of  the occluded 
il!itt l~llHg!ii 
-+  . . . .  - itillJti li!illi iii   
i.: ' :L::i L; : i~ i~ .i 
:r,. , !?~ 
~; i i  i! 
i . . . .  i . . . . . . . . .  . . . .  : i ]  
L - ! -4  . . . . . . . .  ~ i .  ~ ;  
• L..] ~. , ] ! i ~ 
Figure 2. Patient 10. Electrocardiogram (leads V~ to V3) 
recorded at rest, at peak stress and after recovery; ST 
segment elevation is observed uring exercise. 
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Figure 3. Patient 10. Rest myocardial perfusion (left) and positron 
emission tomographic (fight) scans. Left, A perfusion defect involving the 
septum and anterior wall is evident on technetium-99m methoxyisobutyl 
isonitrile single-photon emission computed tomography. Right, Fluo- 
rine-18 fluorodeoxyglucose uptake is observed within the underperfused 
area at positron emission tomography. Trans = transaxial. 
vessel by collateral flow was evident in 13 (93%) of these 
patients (grade 3 in 9 patients, grade 2 in 4). In the remaining 
four patients, the infarct-related artery was open, with critical 
residual narrowing (80 _+ 8%). 
Of the 16 patients in group B, 3 had three-vessel disease, 4
had two-vessel disease, and 8 had one-vessel disease (p = NS 
vs. group A). The remaining patient had only minor irregular- 
ities of the infarct-related coronary artery. The infarct-related 
vessel was occluded in eight patients (50%), of whom five 
(63%) (p -< 0.05 vs. group A) had angiographically visible 
collateral vessels (grade 3 in one patient, grade 2 in four). 
Discussion 
The present study confirms and extends the results of our 
previous investigation (8) by showing that ST segment eleva- 
tion that occurs during exercise testing on leads exploring Q 
wave myocardial infarction reliably indicates the presence of 
residual, within-infarct viable myocardium. This observation is 
of clinical relevance because it provides the background for the 
use of this simple, inexpensive and widely available diagnostic 
procedure for the identification of residual viability in the 
postinfarction period. 
We investigated the significance of ST segment elevation in 
this context by using positron emission tomography with F-18 
fluorodeoxyglucose, a marker of exogenous glucose uptake. In 
fact, this tracer has been shown (10) to detect residual meta- 
bolic activity even when other clinical tests suggest complete 
necrosis. During ischemia, myocardial metabolism is critically 
dependent on glucose utilization because fatty acid oxidation is 
impaired (16): When perfusion is severely reduced, anaerobic 
glycolysis may help support cell survival, although it is insuffi- 
cient for maintaining contractility. Indeed, several investiga- 
tors (4,7,13) have demonstrated that myocardial segments with 
severely depressed contractility and increased glucose uptake 
may contain significant amounts of viable myocardium that 
resume function on revascularization. 
Most patients with ST segment elevation on infarct-related 
leads during exercise had a more recent infarction than those 
without ST segment elevation. This is not surprising because we 
previously showed (17) that residual tissue viability, as assessed by 
fluorodeoxyglucose uptake, cannot persist indefinitely after myo- 
cardial infarction. In fact, patients with a recent infarction have 
significantly larger areas of metabolically active myocardium 
within the necrotic region (17). The higher proportion of patients 
with collateral vessels to the infarcted area also suggests that 
retrograde flow might have contributed to preserve viability in 
group A. 
Of the 18 patients in group A with ST segment elevation on 
exercise testing, only 6 experienced angina. Although the inci- 
dence of chest pain observed in our patients is lower than that 
reported in other studies (18), this percentage (33%) is in 
agreement with that described in patients with a recent myocar- 
dial infarction by Theroux et al. (19) and in a previous report by 
our group (20). 
Whether ischemia or abnormal ventricular wall motion is the 
cause of ST segment elevation during exercise testing in patients 
with a Q wave myocardial infarction has been the subject of a 
number of investigations. Fox et al. (21) studied 24 patients with 
ST segment elevation after myocardial infarction. Because the ST 
segment change was abolished by coronary artery bypass urgery 
in 15 patients, Fox et al. suggested that the underlying mechanism 
was myocardial ischemia. Dunn et al. (22) and Sriwattanakomen 
et al. (23) concluded that ST segment elevation could be due to 
abnormal wall motion or peri-infarction ischemia, or both. Other 
investigators eported that ST segment elevation may result from 
left ventricular aneurysm (24,25), abnormal wall motion (26,27) 
and depressed left ventricular function (28). 
Although no patient in the present study had a true ven- 
tricular aneurysm on ventriculography and two-dimensional 
echocardiography, our results suggest that exercise-induced ST
segment elevation at the site of a previous Q wave myocardial 
infarction reliably indicates the presence of residual viable myo- 
cardium even when regional wall motion is severely abnormal. 
However, although ST segment elevation appears to be highly 
specific, its absence does not necessarily rule out persistence of 
viable tissue. In fact, >50% of the patients without ST segment 
elevation during exercise still had increased F-18 fluorodeoxyglu- 
cose uptake in the infarct area. The larger proportion of patients 
with inferoposterior myocardial infarction included in this group 
may partially account for the relatively high incidence of false 
negative results. Indeed, when analyzed separately, the results 
obtained in patients with an anterior myocardial infarction, both 
sensitivity and predictive accuracy increase to >80%. 
Finally, the finding that left ventricular dysfunction was 
more severe in group A patients may be simply related to the 
much shorter interval elapsed from the myocardial infarction 
and therefore to a greater extent of myocardial stunning. 
Limitations of the study. Our study has methodologic limi- 
tations in that groups A and B are not perfectly matched with 
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regard to site of infarction and time elapsed between its occur- 
rence and enrollment. Furthermore, our results were obtained in 
a group of patients in whom the ST segment of the infarct-related 
leads was nearly isoelectric. The results might had been different 
had patients with rest ST segment abnormalities been enrolled. 
Although F-18 fluorodeoxyglucose uptake is considered the 
reference standard for detection of myocardial viability, some 
problems related to its interpretation have to he considered 
(29,30). Unlike other investigations performed after glucose 
loading, our study used dietary suppression of F-18 fluorode- 
oxyglucose uptake in normal myocardium sothat ischemic but 
metabolically active areas could be identified on the basis of an 
absolute increase in F-18 fluorodeoxyglucose uptake rather 
than by assessing flow/F-18 fluorodeoxyglucose activity ratios 
in the affected regions. With this technique, ven small areas of 
ischemic tissue may show intense uptake of F-18 fluorodeoxy- 
glucose compared with normal myocardium (31,32). Thus, 
under fasting conditions, myocardial F-18 fluorodeoxyglucose 
uptake may overestimate tissue viability, and this might at least 
partially explain the relatively high prevalence of glucose 
uptake within necrotic areas in our group B patients. 
Clinical implications. The results of our study suggest that 
ST segment elevation that occurs on leads exploring an area of 
Q wave myocardial infarction during exercise testing is a 
specific marker of the presence of residual within-infarct viable 
tissue. Patients who exhibit ST segment elevation may benefit 
from revascularization procedures, even when regional wall 
motion is severely impaired. Prospective studies to test this 
hypothesis on the basis of objective measurements of left 
ventricular function are currently under way in our laboratory. 
We thank Orietta Parmesan for secretarial ssistance. 
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